{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:59:53Z","timestamp":1777726793356,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.cgh.2010.02.008","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T04:37:47Z","timestamp":1266467867000},"page":"463-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Important Elements for the Diagnosis of Drug-Induced Liver Injury"],"prefix":"10.1016","volume":"8","author":[{"given":"Vijay K.","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"McHutchison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2010.02.008_bib1","first-page":"64","article-title":"The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center","volume":"39","author":"Galan","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-42641","article-title":"Acute liver failure in the United States","volume":"23","author":"Lee","year":"2003","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2010.02.008_bib3","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.02.008_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/009286158501900327","article-title":"Informativity of adverse reactions data in medical publications","volume":"19","author":"Venulet","year":"1985","journal-title":"Drug Inf J"},{"key":"10.1016\/j.cgh.2010.02.008_bib5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1345\/aph.1D202","article-title":"The quality of published adverse drug event reports","volume":"37","author":"Kelly","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2010.02.008_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2010.02.008_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2010.02.008_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.amjoto.2006.06.007","article-title":"Amoxicillin-clavulanic acid-induced hepatitis","volume":"28","author":"Cundiff","year":"2007","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.cgh.2010.02.008_bib10","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-005-2938-5","article-title":"Acute liver failure due to amoxicillin and amoxicillin\/clavulanate","volume":"50","author":"Fontana","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1023\/A:1010627518254","article-title":"Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin\/clavulanic acid","volume":"46","author":"Andrade","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3476(00)90064-7","article-title":"Rapidly progressive cholestasis: an unusual reaction to amoxicillin\/clavulanic acid therapy in a child","volume":"136","author":"Chawla","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.cgh.2010.02.008_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1572-0241.1998.00418.x","article-title":"An unusual case of amoxicillin\/clavulanic acid-related hepatotoxicity","volume":"93","author":"Nathani","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib14","first-page":"278","article-title":"Focal destructive cholangiopathy associated with amoxycillin\/clavulanic acid (Augmentin)","volume":"23","author":"Ryley","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0168-8278(95)80262-2","article-title":"Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations","volume":"22","author":"Hautekeete","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF00227455","article-title":"Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination","volume":"72","author":"Habior","year":"1994","journal-title":"Clin Investig"},{"key":"10.1016\/j.cgh.2010.02.008_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","article-title":"Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases","volume":"33","author":"Larrey","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.02.008_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-008-1133-6","article-title":"Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone","volume":"51","author":"Julie","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cgh.2010.02.008_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1023\/A:1005505827545","article-title":"Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin","volume":"46","author":"Caldwell","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1572-0241.2001.03809.x","article-title":"Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus","volume":"96","author":"Menon","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib21","first-page":"16","article-title":"Case of the month","volume":"98","author":"Chaudhary","year":"2001","journal-title":"J Ark Med Soc"},{"key":"10.1016\/j.cgh.2010.02.008_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-133-9-200011070-00034","article-title":"Troglitazone-associated hepatotoxicity treated successfully with steroids","volume":"133","author":"Prendergast","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1023\/A:1005510132625","article-title":"Severe but reversible hepatitis induced by troglitazone","volume":"45","author":"Schiano","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1056-8727(00)00076-3","article-title":"Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings","volume":"14","author":"Li","year":"2000","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cgh.2010.02.008_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-132-8-200004180-00021","article-title":"Rapid-onset subfulminant liver failure associated with troglitazone","volume":"132","author":"Jagannath","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1572-0241.2000.01707.x","article-title":"Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration","volume":"95","author":"Kohlroser","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1005405526283","article-title":"Troglitazone-induced fulminant hepatic failure","volume":"45","author":"Murphy","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0046-8177(00)80229-4","article-title":"Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination","volume":"31","author":"Fukano","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cgh.2010.02.008_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1005450519498","article-title":"Hepatic injury due to troglitazone","volume":"45","author":"Malik","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/diacare.23.1.128","article-title":"Late-onset troglitazone-induced hepatic dysfunction","volume":"23","author":"Bell","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2010.02.008_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-130-2-199901190-00021","article-title":"Severe hepatotoxicity associated with troglitazone","volume":"130","author":"Herrine","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.7326\/0003-4819-129-12-199812150-00032","article-title":"Fatal hepatotoxicity associated with troglitazone","volume":"129","author":"Vella","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib33","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/diacare.21.12.2140","article-title":"An autopsy case of troglitazone-induced fulminant hepatitis","volume":"21","author":"Shibuya","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2010.02.008_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-129-1-199807010-00009","article-title":"Troglitazone-induced hepatic failure leading to liver transplantation","volume":"129","author":"Neuschwander-Tetri","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-129-1-199807010-00008","article-title":"Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone","volume":"129","author":"Gitlin","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1345\/aph.1K543","article-title":"Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma","volume":"42","author":"El-Naggar","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2010.02.008_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1464-5491.2006.01791.x","article-title":"Liver failure in a patient receiving rosiglitazone therapy","volume":"23","author":"Su","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.mcg.0000170768.59696.16","article-title":"Hepatic injury in a patient taking rosiglitazone","volume":"39","author":"Menees","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00004836-200205000-00021","article-title":"Rosiglitazone-induced granulomatous hepatitis","volume":"34","author":"Dhawan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib40","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1023\/A:1015895925374","article-title":"Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone","volume":"47","author":"Bonkovsky","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.02.008_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0002-9343(01)00926-3","article-title":"Liver failure in a patient treated with long-term rosiglitazone therapy","volume":"111","author":"Gouda","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-133-8-200010170-00025","article-title":"Rosiglitazone toxicity","volume":"133","author":"Ravinuthala","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7326\/0003-4819-133-9-200011070-00035","article-title":"Isolated elevation of alkaline phosphatase level associated with rosiglitazone","volume":"133","author":"Hachey","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/0003-4819-132-2-200001180-00005","article-title":"Hepatic failure in a patient taking rosiglitazone","volume":"132","author":"Forman","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-132-2-200001180-00006","article-title":"Hepatocellular injury in a patient receiving rosiglitazone","volume":"132","author":"Al-Salman","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1157\/13107492","article-title":"[A new case: pioglitazone hepatotoxicity]","volume":"129","author":"Mart\u00ednez Odriozola","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.cgh.2010.02.008_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0399-8320(04)95021-X","article-title":"[Pioglitazone-induced acute severe hepatitis]","volume":"28","author":"Arot\u00e7arena","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2010.02.008_bib48","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1E072","article-title":"Second-generation thiazolidinediones and hepatotoxicity","volume":"38","author":"Marcy","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2010.02.008_bib49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-137-10-200211190-00023","article-title":"Severe but reversible cholestatic liver injury after pioglitazone therapy","volume":"137","author":"Pinto","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1464-5491.2002.00712_4.x","article-title":"Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success","volume":"19","author":"Nagasaka","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib51","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-136-6-200203190-00008","article-title":"Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy","volume":"136","author":"May","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2002.05516.x","article-title":"Pioglitazone-associated fulminant hepatic failure","volume":"97","author":"Chase","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-135-4-200108210-00029","article-title":"Hepatocellular injury in a patient receiving pioglitazone","volume":"135","author":"Maeda","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s100670200086","article-title":"Vasculitis induced by zafirlukast therapy","volume":"21","author":"Soy","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-135-7-200110020-00019","article-title":"Severe liver injury","volume":"135","author":"Torres","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0168-8278(01)00124-6","article-title":"Acute hepatocellular injury associated with zafirlukast [letter]","volume":"35","author":"Moles","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib57","doi-asserted-by":"crossref","first-page":"930","DOI":"10.7326\/0003-4819-135-10-200111200-00023","article-title":"Severe liver injury associated with zafirlukast [letter]","volume":"135","author":"Danese","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0168-8278(01)00123-4","article-title":"Zafirlukast-related hepatitis: report of a further case [letter]","volume":"35","author":"Actis","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.02.008_bib59","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/0003-4819-133-12-200012190-00011","article-title":"Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast","volume":"133","author":"Reinus","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.dld.2006.10.002","article-title":"Fatal liver failure following food supplements during chronic treatment with montelukast","volume":"39","author":"Actis","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2010.02.008_bib61","doi-asserted-by":"crossref","first-page":"586","DOI":"10.7326\/0003-4819-140-7-200404060-00042","article-title":"Montelukast-induced hepatitis","volume":"140","author":"Goldstein","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2010.02.008_bib62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1572-0241.2003.07316.x","article-title":"A case of montelukast-induced hepatotoxicity","volume":"98","author":"Sass","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.02.008_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0168-8278(03)00085-0","article-title":"Acute hepatitis associated with montelukast","volume":"38","author":"Russmann","year":"2003","journal-title":"J Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:02Z","timestamp":1761541502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356510001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1542356510001485"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2010.02.008","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Important Elements for the Diagnosis of Drug-Induced Liver Injury","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2010.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}